Nanoparticle technology presents key market opportunities in drug delivery, diagnostics, and therapeutic innovations, enhancing drug efficacy and minimizing side effects. Emerging applications in ...

The "Development of Combination Products: Critical Interactions (Sept 16th - Sept 17th, 2026)" has been added to ResearchAndMarkets.com's offering. The medical industry's evolving landscape has ...

This analysis is by Bloomberg Intelligence Industry Analyst Andrew Galler and Senior Associate Analyst Jack Maltby. It appeared first on the Bloomberg Terminal. Life sciences is among the most ...

Pharmaceutical giants such as J&J, Merck, and Eli Lilly are embracing AI and prioritizing upskilling. They hope that training thousands of employees on generative AI will boost productivity in drug ...

The Congressional Budget Office (CBO) informs Congress about the costs or revenue changes associated with proposed legislation, a challenging enough task on its own. Sometimes, the CBO is asked to ...

July 2025 brought a flicker of hope for people with serious health needs: Congress exempted drugs with multiple orphan indications from the Inflation Reduction Act (IRA)’s Medicare Drug Price ...

Designing an efficient platform is crucial for any industrial process. This design process is known as process development, and it has become increasingly important in the pharmaceutical industry at ...

(a) Success rate, timeline, and cost (in billions) of traditional drug development versus RNA drug development, along with a description of the evolutionary progress of the latter. (b) The future ...

Discover how quality-driven drug development and AI accelerate safer medicines, reduce risk, and improve patient outcomes.